Showing posts with label MEN1 gene. Show all posts
Showing posts with label MEN1 gene. Show all posts

May 29, 2012

Knockdown of Menin Affects pre-mRNA Processing

Knockdown of Menin Affects pre-mRNA Processing and Promoter Fidelity at the Interferon-gamma Inducible IRF1 Gene
-Auriemma L, et al. Epigenetics & Chromatin 2012, 5:2 doi:10.1186/1756-8935-5-2.
  • MEN1 contributes to STAT1-activated gene expression in a novel manner that includes defining the transcription start site and RNA processing.
  • IRF1 heteronuclear transcripts become enriched in MEN1-depleted cells.

Multiple endocrine neoplasia type 1

Multiple endocrine neoplasia type 1
-Wikipedia
  • An overview of MEN1.

Multiple endocrine neoplasia type 1: a chromatin writer’s block

Multiple endocrine neoplasia type 1: a chromatin writer’s block -Dreijerink, K. M. A., Lips, C. J. M. and Timmers, H. T. M. (2009). Journal of Internal Medicine, 266: 53–59. doi: 10.1111/j.1365-2796.2009.02115.x
  • Menin is important for the writing of histone H3K4 trimethylation.
  • In MEN1 tumors, writing of H3K4me3 on specific target genes is blocked.
  • Compounds that interfere with the removal of the histone methylation mark are being developed.
  • Specific targeting of menin-HMT to treat tumors poses a great challenge for future research.

February 28, 2012

The amino acid sequence of menin

The human gene MEN1 (also the name of the disorder associated with a mutant MEN1 gene) encodes the protein menin. UniProt specifies three isoforms of menin, Isoform 1 being called the 'canonical' sequence.1 It is 615 amino acids in length, the others being 610 and 575 amino acids in length, respectively.

Menin Isoform 1:
10 20 30 40 50 60 MGLKAAQKTL FPLRSIDDVV RLFAAELGRE EPDLVLLSLV LGFVEHFLAV NRVIPTNVPE 70 80 90 100 110 120 LTFQPSPAPD PPGGLTYFPV ADLSIIAALY ARFTAQIRGA VDLSLYPREG GVSSRELVKK 130 140 150 160 170 180 VSDVIWNSLS RSYFKDRAHI QSLFSFITGW SPVGTKLDSS GVAFAVVGAC QALGLRDVHL 190 200 210 220 230 240 ALSEDHAWVV FGPNGEQTAE VTWHGKGNED RRGQTVNAGV AERSWLYLKG SYMRCDRKME 250 260 270 280 290 300 VAFMVCAINP SIDLHTDSLE LLQLQQKLLW LLYDLGHLER YPMALGNLAD LEELEPTPGR 310 320 330 340 350 360 PDPLTLYHKG IASAKTYYRD EHIYPYMYLA GYHCRNRNVR EALQAWADTA TVIQDYNYCR 370 380 390 400 410 420 EDEEIYKEFF EVANDVIPNL LKEAASLLEA GEERPGEQSQ GTQSQGSALQ DPECFAHLLR 430 440 450 460 470 480 FYDGICKWEE GSPTPVLHVG WATFLVQSLG RFEGQVRQKV RIVSREAEAA EAEEPWGEEA 490 500 510 520 530 540 REGRRRGPRR ESKPEEPPPP KKPALDKGLG TGQGAVSGPP RKPPGTVAGT ARGPEGGSTA 550 560 570 580 590 600 QVPAPTASPP PEGPVLTFQS EKMKGMKELL VATKINSSAI KLQLTAQSQV QMKKQKVSTP 610 SDYTLSFLKR QRKGL
The table contains standardized single-letter codes for the various amino acids. Wikipedia offers a table describing these codes.2
For example, the "Q" at amino acid position 64 represents glutamine, which is encoded either by codons CAA or CAG.3
__________
1 UniProt entry on "MEN1_HUMAN"
2 http://en.wikipedia.org/wiki/Amino_acid#Table_of_standard_amino_acid_abbreviations_and_properties (Wikipedia: Amino Acid).
3 http://en.wikipedia.org/wiki/Genetic_code#RNA_codon_table (Wikipedia: Genetic Code).

February 8, 2012

DNA methylation

Allfrey in 1964 described methylation as a chemical mark upon histones.[Ref.1] According to newer sources, methylation also takes place on some CpG sequences of the DNA itself.[Ref.11] CpG denotes a cytosine base next to a guanine base, a combination that tends to occur frequently. A methyl group (CH3) may attach to the cytosine in a CpG pair, forming Me-CpG. DNA methylation is associated with the regulation of gene expression.

In human DNA about 80%-90% of CpG sites are methylated, but there are certain areas known as CpG islands where none of the sites are methylated. These are associated with the promoters of 56% of mammalian genes, including all ubiquitously expressed genes. (1)

MEN1 is a ubiquitously expressed gene[Ref.6], so it would seem that we should take a closer look at methylation.
__________

(1)Methylation. Wikipedia.

January 7, 2012

What is MEN1?

Multiple Endocrine Neoplasia Type 1 is a genetic disorder that greatly increases the risk of developing multiple cancerous and noncancerous tumors in glands such as the parathyroid, pituitary, and pancreas. These endocrine tumors may produce excessive levels of hormones that lead to secondary disease.

Individuals with MEN1 are born with one mutated copy of the MEN1 tumor suppressor gene in each cell. Cells that later develop a mutation in the remaining copy of the MEN1 gene then are left unable to produce menin, an important tumor suppressor protein. With no functional MEN1 gene, such cells may divide uncontrollably, resulting in the development of tumors.

MEN1 is also known as: MEN Type 1, MEN-1, Multiple Endocrine Adenomatosis Type 1, MEA Type 1, MEA 1, Wermer's syndrome.

references:
http://www.mayoclinic.org/men1/
http://en.wikipedia.org/wiki/Multiple_endocrine_neoplasia_type_1